Expert Review of Anti-Infective Therapy

Article	Citations
An update on COVID-19 pandemic: the epidemiology, pathogenesis, prevention and treatment strategies	169
Azithromycin in the treatment of COVID-19: a review	159
COVID-19 and cardiac injury: clinical manifestations, biomarkers, mechanisms, diagnosis, treatment, and follow up	150
Resolution of coronavirus disease 2019 (COVID-19)	110
An overview of tecovirimat for smallpox treatment and expanded anti-orthopoxvirus applications	101
The use of IV vitamin C for patients with COVID-19: a case series	98
Sepsis-associated encephalopathy and septic encephalitis: an update	94
Antimicrobial resistance in low- and middle-income countries: current status and future directions	81
Exercise and well-being during COVID 19 – time to boost your immunity	76
Quorum quenching enzymes and their effects on virulence, biofilm, and microbiomes: a review of recent advances	73
Functionalized carbon-based nanomaterials and quantum dots with antibacterial activity: a review	68
Can nanotechnology help in the fight against COVID-19?	65
Meropenem/vaborbactam: a next generation β-lactam β-lactamase inhibitor combination	62
COVID-19: fighting the invisible enemy with microRNAs	62
Calycosin: a Review of its Pharmacological Effects and Application Prospects	54
Moxidectin: an oral treatment for human onchocerciasis	51
Virulence factors, antibiotic resistance patterns, and molecular types of clinical isolates of Klebsiella Pneumoniae	50
Point prevalence surveys of antimicrobial use: a systematic review and the implications	47
CAR-T cell therapy and infection: a review	47
Alternative approaches to treat bacterial infections: targeting quorum-sensing	46
COVID-19 and vitamin D (Co-VIVID study): a systematic review and meta-analysis of randomized controlled trials	45
Old and re-purposed drugs for the treatment of COVID-19	44
Antimicrobial consumption in patients with COVID-19: a systematic review and meta-analysis	44
Update on the epidemiology of carbapenemases in Latin America and the Caribbean	43
Current and emerging strategies to combat antimalarial resistance	41

Improper disposal of unused antibiotics: an often overlooked driver of antimicrobial resistance	40
Cytokine storm associated coagulation complications in COVID-19 patients: Pathogenesis and Management	39
Multidrug-resistantCandida auris: an epidemiological review	38
Progress on the national action plan of Pakistan on antimicrobial resistance (AMR): a narrative review and the implications	35
MATH+ protocol for the treatment of SARS-CoV-2 infection: the scientific rationale	34
Loss of smell and taste: a new marker of COVID-19? Tracking reduced sense of smell during the coronavirus pandemic using search trends	34
Antimicrobial peptides and other peptide-like therapeutics as promising candidates to combat SARS-CoV-2	33
Tackling Antimicrobial Resistance by promoting Antimicrobial stewardship in Medical and Allied Health Professional Curricula	32
A point prevalence survey of antimicrobial utilisation patterns and quality indices amongst hospitals in South Africa; findings and implications	31
Diagnostic accuracy of the Xpert MTB/RIF assay for abdominal tuberculosis: a systematic review and meta-analysis	30
Fungal sphingolipids: role in the regulation of virulence and potential as targets for future antifungal therapies	30
Nanomaterials as drug delivery systems with antibacterial properties: current trends and future priorities	29
Tocilizumab for patients with severe COVID-19: a retrospective, multi-center study	28
All-cause mortality rates in adults with carbapenem-resistant Gram-negative bacterial infections: a comprehensive review of pathogen-focused, prospective, randomized, interventional clinical studies	28
Efflux pump inhibitors as a promising adjunct therapy against drug resistant tuberculosis: a new strategy to revisit mycobacterial targets and repurpose old drugs	28
Bacterial death from treatment with fluoroquinolones and other lethal stressors	28
Hydroxychloroquine in the COVID-19 pandemic era: in pursuit of a rational use for prophylaxis of SARS-CoV-2 infection	28
Addressing antimicrobial resistance in Nigerian hospitals: exploring physicians prescribing behavior, knowledge, and perception of antimicrobial resistance and stewardship programs	28
RETRACTED ARTICLE: Efficacy of combined Sofosbuvir and Daclatasvir in the treatment of COVID-19 patients with pneumonia: a multicenter Egyptian study	27
Use of Xpert MTB/RIF and Xpert Ultra in extrapulmonary tuberculosis	27
Topical delivery of growth factors and metal/metal oxide nanoparticles to infected wounds by polymeric nanoparticles: an overview	27
Vitamin D attenuates COVID-19 complications via modulation of proinflammatory cytokines, antiviral proteins, and autophagy	27
Management strategies for human babesiosis	27
Bacteria and fungi as major bio-sources to fabricate silver nanoparticles with antibacterial activities	26
A review on favipiravir: the properties, function, and usefulness to treat COVID-19	25
Janus kinase (JAK)-inhibitors and coronavirus disease 2019 (Covid-19) outcomes: a systematic review and meta-analysis	25
Multidrug-resistant Klebsiella pneumoniae: mechanisms of resistance including updated data for novel β-lactam-β-lactamase inhibitor combinations	25
Antibiotic resistant bacteria: current situation and treatment options to accelerate the development of a new antimicrobial arsenal	25
Carbapenemase producing Klebsiella pneumoniae: implication on future therapeutic strategies	24
Efficacy and safety of dalbavancin in the treatment of acute bacterial skin and skin structure infections (ABSSSIs) and other infections in a real-life setting: data from an Italian observational mult	24
Antibiotic consumption among hospitalized neonates and children in Punjab province, Pakistan	23
Therapeutic strategies to address monkeypox	23
Repurposed anti-cancer drugs: the future for anti-infective therapy?	23
Incidence and risk factors of carbapenem-resistantEnterobacteriaceaeinfection in intensive care units: a matched case–control study	23
Repurposing of well-known medications as antivirals: hydroxychloroquine and chloroquine – from HIV-1 infection to COVID-19	22
Dengue vaccine: an update	22
Nanotechnology-based promising strategies for the management of COVID-19: current development and constraints	22
Quorum sensing: a new prospect for the management of antimicrobial-resistant infectious diseases	22
Possible therapeutic agents for COVID-19: a comprehensive review	22
Proposed amendments regarding the definitions of multidrug-resistant and extensively drug-resistant bacteria	22
Repurposing minocycline for COVID-19 management: mechanisms, opportunities, and challenges	21
Repurposing therapeutic agents against SARS-CoV-2 infection: most promising and neoteric progress	21
Benznidazole for the treatment of Chagas disease	21
Therapeutic drug monitoring of β-lactam antibiotics in the ICU	20
Role of vacuolating cytotoxin A in Helicobacter pylori infection and its impact on gastric pathogenesis	20
Helminths, hosts, and their microbiota: new avenues for managing gastrointestinal helminthiases in ruminants	19
A systematic literature review to assess the burden of herpes zoster disease in China	19
A multicentre point prevalence survey of hospital antibiotic prescribing and quality indices in the Kurdistan regional government of Northern Iraq: the need for urgent action	19
Novel corona virus (COVID-19) pandemic: current status and possible strategies for detection and treatment of the disease	19
Detection of SARS-CoV-2 by antigen ELISA test is highly swayed by viral load and sample storage condition	18

Cardiovascular disease in HIV patients: recent advances in predicting and managing risk	18
Quadruple therapy for asymptomatic COVID-19 infection patients	17
Impact of bacterial infections on erythropoiesis	17
Jumping into the future: overcoming pharmacokinetic/pharmacodynamic hurdles to optimize the treatment of severe difficult to treat-Gram-negative infections with novel beta-lactams	16
Treatment of carbapenem-resistantPseudomonas aeruginosainfections: a case for cefiderocol	16
The war against bacteria, from the past to present and beyond	16
The democratization of de-labeling: a review of direct oral challenge in adults with low-risk penicillin allergy	16
A review of current treatment strategies for infective endocarditis	16
Implementation of antimicrobial stewardship to reduce antimicrobial drug resistance	15
Drug repurposing: new strategies for addressing COVID-19 outbreak	15
Non-antibiotic antibacterial peptides and proteins of Escherichia coli: efficacy and potency of bacteriocins	15
Public knowledge, attitude, and practice regarding antibiotics use in Punjab, Pakistan: a cross-sectional study	15
A multicentre point prevalence study of antibiotics utilization in hospitalized patients in an urban secondary and a tertiary healthcare facilities in Nigeria: findings and implications	15
Recent advances in the understanding of enterovirus A71 infection: a focus on neuropathogenesis	15
NSAIDs/nitazoxanide/azithromycin repurposed for COVID-19: potential mitigation of the cytokine storm interleukin-6 amplifier via immunomodulatory effects	15
Knowledge, attitude and practices among consumers toward antibiotics use and antibiotic resistance in Swat, Khyber-Pakhtunkhwa, Pakistan	15
Drug discovery for primary amebic meningoencephalitis: from screen to identification of leads	15
Treatment strategies for OXA-48-like and NDM producing Klebsiella pneumoniae infections	15
Adjuvant use of combination of antibiotics in acute severe ulcerative colitis: A placebo controlled randomized trial	14
Fecal microbiota transplantation for treatment of patients with recurrent Clostridioides difficile infection	14
The rise of mucormycosis in Covid-19 patients in India	14
Plazomicin: an intravenous aminoglycoside antibacterial for the treatment of complicated urinary tract infections	14
Integrative role of traditional and modern technologies to combat COVID-19	14
Endemic mycoses: epidemiology and diagnostic strategies	14
Acanthamoeba Keratitis: an update on amebicidal and cysticidal drug screening methodologies and potential treatment with azole drugs	14
Managing sepsis in the era of precision medicine: challenges and opportunities	14
Intravenous fosfomycin for the treatment of patients with central nervous system infections: evaluation of the published evidence	14
Cryptococcal meningitis: a review of cryptococcal antigen screening programs in Africa	14
Caspofungin: a review of its characteristics, activity, and use in intensive care units	13
Diagnosis of clinical malaria in endemic settings	13
Intravenous fosfomycin for the treatment of patients with bone and joint infections: a review	13
Cabotegravir/Rilpivirine: the last FDA-approved drug to treat HIV	13
Emerging from the screening of 57 million citizens and treating 4 million patients: future strategies to eliminate hepatitis C from Egypt	13
Evaluation of favipiravir in the treatment of COVID-19 based on the real-world	13
Knowledge, attitude, and practices of community pharmacy staff toward antimicrobial stewardship programs: a cross-sectional study from Northeastern China	13
Diagnosis, prevention, and treatment of coronavirus disease: a review	13
Predictors of mortality in invasive pneumococcal disease: a meta-analysis	13
The enemy at home: leishmaniasis in the Mediterranean basin, Italy on the focus	13
‘Secondary prevention’ against female HPV infection: literature review of the role of carrageenan	13
Bacteriophages for ESKAPE: role in pathogenicity and measures of control	13
Precision medicine for the diagnosis and treatment of carbapenem-resistant Enterobacterales: time to think from a different perspective	12
Porphyromonas gingivalis infection may contribute to systemic and intracerebral amyloid-beta: implications for Alzheimer’s disease onset	12
Corticosteroids in SARS-COV2 infection: certainties and uncertainties in clinical practice	12
Antifungal susceptibility testing in Candida species: current methods and promising new tools for shortening the turnaround time	12
Efficacy and safety of lopinavir/ritonavir in the treatment of COVID-19: A systematic review	12
The potential for CXCL13 in CSF as a differential diagnostic tool in central nervous system infection	12
Anti-inflammatory effects of GLP-1 in patients with COVID-19	12
Healthcare-associated ventriculitis: current and emerging diagnostic and treatment strategies	12
Fostemsavir for the treatment of HIV	12
COVID-19 and cardiovascular complications: an update from the underlying mechanism to consequences and possible clinical intervention	12
Potential utility of nano-based treatment approaches to address the risk ofHelicobacter pylori	11
Global travel and Gram-negative bacterial resistance; implications on clinical management	11
Novel strategies for rapid identification and susceptibility testing of MRSA	11
Exacerbation of antimicrobial resistance: another casualty of the COVID-19 pandemic?	11
Clinical impact of procalcitonin-based algorithms for duration of antibiotic treatment in critically ill adult patients with sepsis: a meta-analysis of randomized clinical trials	11
The role of dalbavancin for Gram positive infections in the COVID-19 era: state of the art and future perspectives	11
The antifungal activity of caspofungin in combination with antifungals or non-antifungals against Candida species in vitro and in clinical therapy	11
Natural and vaccine-induced B cell-derived systemic and mucosal humoral immunity to human papillomavirus	11
Self-medication Behavior with antibiotics: a national cross-sectional survey in Sri Lanka	11
Molecular diagnosis of toxoplasmosis: recent advances and a look to the future	11
Low pH Hypromellose (Taffix) nasal powder spray could reduce SARS-CoV-2 infection rate post mass-gathering event at a highly endemic community: an observational prospective open label user survey	11
Management of osteoarticular fungal infections in the setting of immunodeficiency	10
Sepsis in the critically ill patient: current and emerging management strategies	10
Streptogramins for the treatment of infections caused by Gram-positive pathogens	10
Current rates of purchasing of antibiotics without a prescription across sub-Saharan Africa; rationale and potential programmes to reduce inappropriate dispensing and resistance	10
Recent molecules in the treatment of severe infections caused by ESBL-producing bacteria	10
Preventing catheter-related infections in cancer patients: a review of current strategies	10
Discovery of novel antischistosomal scaffolds from the open access Pandemic Response Box	10
Recent innovations and new applications of outpatient parenteral antimicrobial therapy	10
Impact of HIV infection on aging and immune status	10
Spontaneous loss of chronic HBV infection markers in treatment-naïve children: a systematic review and pooled meta-analyses	10
Host–pathogen interaction inCandida glabratainfection: current knowledge and implications for antifungal therapy	10
Continuous infusion of beta-lactam antibiotics: narrative review of systematic reviews, and implications for outpatient parenteral antibiotic therapy	10
Optimization of Ganciclovir use in allogeneic hematopoietic cell transplant recipients – the role of therapeutic drug monitoring	10
Comparison of tailored Helicobacter pylori eradication versus modified bismuth quadruple therapy in Korea: a randomized controlled trial	10
Adolescents and young adults with early acquired HIV infection in the united states: unique challenges in treatment and secondary prevention	10
Inflammation in neurocysticercosis: clinical relevance and impact on treatment decisions	10
An update on endotoxin neutralization strategies in Gram-negative bacterial infections	10
Bacterial resistance to antibiotics: access, excess, and awareness in Bangladesh	9
Emergence of varicella-zoster virus resistance to acyclovir: epidemiology, prevention, and treatment	9

Lifestyle and rehabilitation during the COVID-19 pandemic: guidance for health professionals and support for exercise and rehabilitation programs	9
Reemergence of monkeypox: prevention and management	9
Lack of antibiotic knowledge and misuse of antibiotics by medical students in Mali: a cross-sectional study	9
Management of fever and neutropenia in the adult patient with acute myeloid leukemia	9
Clinical characteristics and outcomes in adult patients hospitalized with influenza, respiratory syncytial virus and human metapneumovirus infections	9
Current updates in diagnosis of male urogenital tuberculosis	9
Transmission dynamics of dengue and chikungunya in a changing climate: do we understand the eco-evolutionary response?	9
Triclabendazole for the treatment of human fascioliasis and the threat of treatment failures	9
The immunology of SARS-CoV-2 infection, the potential antibody based treatments and vaccination strategies	9
Investigating forthcoming strategies to tackle deadly superbugs: current status and future vision	9
Polymyxin combination therapy for multidrug-resistant, extensively-drug resistant, and difficult-to-treat drug-resistant gram-negative infections: is it superior to polymyxin monotherapy?	9
Application of platelet-rich plasma in traumatic bone infections	9
The mechanisms and safety of probiotics against toxigenic clostridium difficile	9
Low risk of HBV reactivation in a large European cohort of HCV/HBV coinfected patients treated with DAA	9
Medicinal plants consumption against urinary tract infections: a narrative review of the current evidence	9
The effect of antivirals on COVID-19: a systematic review	9
Potential effectiveness and adverse implications of repurposing doxycycline in COVID-19 treatment	9
Total mouth photodynamic therapy mediated by blue led and curcumin in individuals with AIDS	8
Possible effects of Porphyromonas gingivalis on the blood–brain barrier in Alzheimer’s disease	8
Current approaches to cysticidal drug therapy for neurocysticercosis	8
Risk of infection in patients with hematological malignancies receiving CAR T-cell therapy: systematic review and meta-analysis	8
Further understanding of Pseudomonas aeruginosa’s ability to horizontally acquire virulence: possible intervention strategies	8
Outpatient treatment options to address the SARS-CoV-2 variant Omicron	8
Multicenter surveillance of in vitro activities of cefepime-zidebactam, cefepime-enmetazobactam, omadacycline, eravacycline, and comparator antibiotics against Enterobacterales, Pseudomonas	8
Understanding host responses to equine encephalitis virus infection: implications for therapeutic development	8
Antibiotic use among hospitalized children with lower respiratory tract infections: a multicenter, retrospective study from Punjab, Pakistan	8
Indomethacin: an exploratory study of antiviral mechanism and host-pathogen interaction in COVID-19	8
Scrub typhus and antibiotic-resistant Orientia tsutsugamushi	8
Recent progress in the repurposing of drugs/molecules for the management of COVID-19	8
Challenges in the prevention or treatment of RSV with emerging new agents in children from low- and middle-income countries	8
The use of remdesivir for the management of patients with moderate-to-severe COVID-19: a systematic review	8
Is the vaginal cleansing product industry causing harm to women?	8
Accuracy of blood-tests and synovial fluid-tests in the diagnosis of periprosthetic joint infections	8
Brain-eating amoebae: is killing the parasite our only option to prevent death?	8
Pharmacological management of antifungal agents in pulmonary aspergillosis: an updated review	8
Prevalence and determinants of self-medication with antibiotics among general population in Afghanistan	8
Visceral leishmaniasis elimination in India: progress and the road ahead	7
Acute Bacterial Skin and Skin-Structure Infections, efficacy of Dalbavancin: a systematic review and meta-analysis	7
Containment strategies for COVID-19 in India: lessons from the second wave	7
Strengths and caveats of identifying resistance genes from whole genome sequencing data	7
Lactic acid bacteria: prominent player in the fight against human pathogens	7
Antiviral drugs for coronavirus disease 2019 (COVID-19): a systematic review with network meta-analysis	7
Vitamin D and immuno-pathology of COVID-19: many interactions but uncertain therapeutic benefits	7
Managing Viral Emerging Infectious Diseases via current Molecular Diagnostics in the Emergency Department: the Tricky Cases	7
An evidence-based multidisciplinary approach focused at creating algorithms for targeted therapy of infection-related ventilator associated complications (IVACs) caused by Enterobacterales in critical	7
Prevalence of antibiotic self-medication behavior and related factors among children aged 0 to 5 years	7
Systematic Review and Meta-Analysis: Efficacy of Vancomycin Taper and Pulse Regimens in Clostridioides difficile Infection	7
The antifungal pipeline for invasive fungal diseases: what does the future hold?	7
The value of infectious disease modeling and trend assessment: a public health perspective	7
Antibiotic resistant profile of asymptomatic bacteriuria in pregnant women: a systematic review and meta-analysis	7
Bacterial infection during wars, conflicts and post-natural disasters in Asia and the Middle East: a narrative review	7
Clinical efficacy and safety of interferon-β–containing regimens in the treatment of patients with COVID-19: a systematic review and meta-analysis of randomized controlled trials	7
SIRS, SOFA, qSOFA, and NEWS in the diagnosis of sepsis and prediction of adverse outcomes: a systematic review and meta-analysis	7
Leprosy: why does it persist among us?	7
Secnidazole: a treatment for trichomoniasis in adolescents and adults	6
What are the origins of growing microbial resistance? Both Lamarck and Darwin were right	6
Call for proper documentation of COVID-19 deaths in poor resource setting: a necessity for management of future occurrences	6
Acute bacterial skin and skin structure infections in pediatric patients: potential role of dalbavancin	6
Janus kinase inhibitors for hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials	6
Challenges in TB regimen development: preserving evidentiary standards for regulatory decisions and policymaking	6
Clostridioides difficile infection: an emerging zoonosis?	6
Cannabis use and reduced risk of elevated fatty liver index in HIV-HCV co-infected patients: a longitudinal analysis (ANRS CO13 HEPAVIH)	6
Nucleos(t)ide analogues for the treatment of chronic hepatitis B: a systematic review with network meta-analysis	6
New advances in management and treatment of multidrug-resistant Klebsiella pneumoniae	6
Pharmacological interventions for COVID-19: a systematic review of observational studies and clinical trials	6
Clinical efficacy and safety of ceftobiprole in the treatment of acute bacterial skin and skin structure infection: a systematic review and meta-analysis of randomized controlled trials	6
A profile of the live biotherapeutic product RBX2660 and its role in preventing recurrent Clostridioides difficile infection	6
Antifungal effects and potential mechanisms of lonidamine in combination with fluconazole against Candida albicans	6
Neonatal ocular prophylaxis in the United States: is it still necessary?	5
Antimicrobial prescribing for treatment of serious infections caused by Staphylococcus aureus and methicillin-resistant Staphylococcus aureus in pediatrics: an expert review	5
Diagnostic imaging in infective endocarditis: a contemporary perspective	5
Direct acting antivirals are associated with more liver stiffness regression than pegylated interferon therapy in chronic hepatitis C patients	5
Clinical outcomes of sofosbuvir-based antivirals in patients with COVID-19: a systematic review and meta-analysis of randomized trials	5
Diagnostic stewardship based on patient profiles: differential approaches in acute versus chronic infectious syndromes	5
Statin use and impact on tuberculosis risk	5
Epidemiology and microbiology of Gram-negative bloodstream infections in a tertiary-care hospital in Beijing, China: a 9-year retrospective study	5
The efficacy and safety of ceftolozane-tazobactam in the treatment of GNB infections: a systematic review and meta-analysis of clinical studies	5
Efficacy and acceptability of different anti-fungal interventions in oropharyngeal or esophageal candidiasis in HIV co-infected adults: a pilot network meta-analysis	5
Oteseconazole: a long-awaited diversification of the antifungal arsenal to manage recurrent vulvovaginal candidiasis (RVVC)	5
Azithromycin in the treatment of rectogenitalChlamydia trachomatisinfections: end of an era?	5
Harnessing the potential of CRISPR-based platforms to advance the field of hospital medicine	5
How can we improve uptake of oral HIV pre-exposure prophylaxis for transgender individuals?	5
A survey of knowledge, attitudes and practices concerning antibiotic prescription for upper respiratory tract infections among pediatricians in 2018 in Shaanxi Province, China	5
New perspectives in the antibiotic treatment of mechanically ventilated patients with infections from Gram-negatives	5
Androgen receptor, a possible anti-infective therapy target and a potent immune respondent in SARS-CoV-2 spike binding: a computational approach	5
Therapeutic drug monitoring (TDM) in real-time: a need for the present future	5
Delafloxacin for the treatment of adult patients with community-acquired bacterial pneumonia	5
Antimicrobial pharmacokinetics and preclinicalin vitromodels to support optimized treatment approaches for uncomplicated lower urinary tract infections	5
Assessing sex differential in COVID-19 mortality rate by age and polymerase chain reaction test results: an Iranian multi-center study	5
Harmonizing antibiotic regimens with renal replacement therapy	5
Efficacy and appropriateness of novel antibiotics in response to antimicrobial-resistant gram-negative bacteria in patients with sepsis in the ICU	5
Treatment of ventilator-associated pneumonia due to carbapenem-resistant Gram-negative bacteria with novel agents: a contemporary, multidisciplinary ESGCIP perspective	5
Prevalence of antimicrobial use in a tertiary academic hospital: a venue for antimicrobial stewardship programs	5
Use of hydroxychloroquine for pre-exposure prophylaxis in COVID 19: debate and suggested future course	5
Real-world discontinuations due to neuropsychiatric symptoms in people living with HIV treated with second-generation integrase inhibitors: a systematic review	4